Arixtra Related Clinical Trials
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer [Recruiting]
Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT) [Recruiting]
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers [Completed]
A Pilot Study Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients [Recruiting]
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients [Recruiting]
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis [Recruiting]
Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency [Recruiting]
Special Drug Use Investigation (Retrospective) for Arixtra� (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg) [Not yet recruiting]
Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia [Recruiting]
Special Drug Use Investigation for Arixtra� (Fondaparinux) Venous Thromboembolism Treatment [Not yet recruiting]
The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty [Not yet recruiting]
Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI [Recruiting]
Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure. [Recruiting]
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux [Recruiting]
Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication [Not yet recruiting]
Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy [Withdrawn]
Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism [Recruiting]
Fondaparinux in Critically Ill Patients With Renal Failure [Recruiting]
"Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction" [Recruiting]
ARIXTRA Local Study For Registration In China. [Completed]
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis [Recruiting]
Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism [Recruiting]
Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression [Recruiting]
Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study [Not yet recruiting]
Fondaparinux Population Pharmacokinetic to Morbid Obese Patients in Post-operatory Bariatric Surgery [Recruiting]
Study of Arixtra to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy [Recruiting]
Study to Determine Effective Dosing of Fondaparinux in Obese Persons [Recruiting]
Fondaparinux in Patients With Acute HIT [Recruiting]
Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism [Completed]
Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm [Recruiting]
Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction [Recruiting]
Prospective, Multicentre, Open-Label Study Evaluating 1,5 mg/Day of Fondaparinux. [Recruiting]
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery [Recruiting]
Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures [Recruiting]
Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux [Terminated]
Determination of Residual Anticoagulatory Effects of Fondaparinux [Recruiting]
Fondaparinux Trial With UFH During Revascularization in Acute Coronary Syndromes [Recruiting]
Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) [Completed]
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients [Recruiting]
Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients [Completed]
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer [Recruiting]
Michelangelo – Oasis 5 [Completed]
Safety Study of Fondaparinux Sodium to Prevent Venous Thromboembolic Events (APOLLO) [Completed]
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI) [Completed]
Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients [Not yet recruiting]
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients [Recruiting]
Hip Fracture Study of GSK576428 (Fondaparinux Sodium) [Completed]
Registry of Hospitalized Patients Treated With Fondaparinux [Active, not recruiting]
Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery [Recruiting]
Oral Direct Factor Xa-Inhibitor Apixaban in Patients With Acute Symptomatic Deep-Vein Thrombosis-The Botticelli DVT Study [Completed]
Xarelto Regulatory Post-Marketing Surveillance [Recruiting]
Tranexamic Acid in HIp Fracture Surgery (THIF Study) [Terminated]
Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin [Not yet recruiting]
Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients [Recruiting]
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy [Recruiting]
Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin. [Recruiting]
|
